Sutro Biopharma, Inc.: Form 8-K, filed Nov 27, 2023
Filed with the SEC on Nov 27, 2023 and accepted by EDGAR at Nov 27, 2023, 16:05 ET.
Items reported
- Item 1.01 Entry into a material agreement
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-23-066112. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.